Integrating Siderophore Substructures in Thiol-Based Metallo-β-Lactamase Inhibitors

3Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Metallo beta lactamases (MBLs) are among the most problematic resistance mechanisms of multidrug-resistant Gram-negative pathogens due to their broad substrate spectrum and lack of approved inhibitors. In this study, we propose the integration of catechol substructures into the design of thiol-based MBL inhibitors, aiming at mimicking bacterial siderophores for the active uptake by the iron acquisition system of bacteria. We synthesised two catechol-containing MBL inhibitors, as well as their dimethoxy counterparts, and tested them for in vitro inhibitory activity against NDM-1, VIM-1, and IMP-7. We demonstrated that the most potent catechol-containing MBL inhibitor is able to bind Fe3+ ions. Finally, we could show that this compound restores the antibiotic activity of imipenem in NDM-1-expressing K. pneumoniae, while leaving HUVEC cells completely unaffected. Thus, siderophore-containing MBL inhibitors might be a valuable strategy to overcome bacterial MBL-mediated resistance to beta lactam antibiotics.

Cite

CITATION STYLE

APA

Rotter, M. J., Zentgraf, S., Weizel, L., Frank, D., Burgers, L. D., Brunst, S., … Proschak, E. (2023). Integrating Siderophore Substructures in Thiol-Based Metallo-β-Lactamase Inhibitors. Molecules, 28(4). https://doi.org/10.3390/molecules28041984

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free